11.19.25 -- Biotech Funding, China Trials, And NAYA's Strategy

Social proof—seeing peers safely participate—reduces fear and builds trust in clinical trials. Sharing real stories and community support normalizes participation and boosts enrollment decisions.

Explore the transformative shift towards digital patient recruitment in clinical trials and the persistent challenges of traditional methods that often lead to significant enrollment failures.

As recombinant protein-based products accelerate toward IND, reliable process development methods are critical to meet demand. Review case studies to learn how expedited timelines can be achieved.

Gain a comprehensive overview of how sponsors can accelerate clinical trial start-up in Australia, leveraging the nation’s unique strengths as a global hub for clinical research.

AAV has become an increasingly popular vector for gene therapy applications, yet ongoing challenges related to process and analytical development often require significant expertise to navigate.

Drug development accelerates with AI, decentralized trials, and adaptive protocols, but legacy CRO infrastructure lags. Platform-based systems enable speed, quality, automation, and continuous improvement.

Discover a strategy of building a global network of modular-designed large-scale and single-use facilities to allow customers to rapidly ramp up production and transfer processes.